Inogen Inc (INGN) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US45780L1044
Inogen Inc financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 348.67 m USD |
| Gross profit | 154.27 m USD |
| Operating income | -30.21 m USD |
| EBIT | -27.76 m USD |
| Net income | -22.75 m USD |
| Diluted EPS – continuing operations | -0.86 USD |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
More stocks
- Kyochon F And B Co Ltd (339770.KS)
- Calin Technology Co Ltd (4976.TW)
- LIWANLI Innovation Co Ltd (3054.TW)
- MOTORCAR PARTS OF AMERICA INC (MPAA)
- Husteel (005010.KS)
- TTEC Holdings, Inc. (TTEC)
- Surya Fajar Capital Tbk PT (SFAN.JK)
- Aeluma, Inc. (ALMU)
- Naturhouse Health SA (NTH.MC)
- Ready Capital Corp (RC)
- Ekter SA (EKTER.AT)
- The BORN Korea (475560.KS)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.